Morgan Stanley maintains Rocket Lab at Overweight, lowers price target to $103 from $105

What happened

Morgan Stanley kept its Overweight rating on Rocket Lab but lowered its price target to $103 from $105, a 1.9% decrease. The new target implies 64.2% upside from Rocket Lab’s November 10 closing price of $62.71.

Confirmed

Global impact / market context

The lower target signals a modest reduction in Morgan Stanley’s valuation view, while its Overweight rating remains unchanged. For investors, the target is an analyst estimate, not a guaranteed return; it may shape expectations but does not directly change Rocket Lab’s sales, costs, or cash available.

Analyst inference

The article lists five recent analyst notes with targets from $58 to $100, while Morgan Stanley’s new $103 target is above that range. Ratings vary from Buy or Overweight to Neutral, showing that analysts do not share one view of Rocket Lab’s value.

Confirmed

What to watch

1. Compare future Morgan Stanley updates with Rocket Lab’s reported business results; a further target change or rating shift would show whether the firm’s view is changing. Analyst inference
2. Watch whether other analysts revise their ratings or targets, since the listed recent targets range from $58 to $100 and their views differ. Analyst inference
3. Track Rocket Lab’s share price against the stated $103 target and the November 10 close of $62.71; the target is an estimate, not a promised outcome. Analyst inference

Evidence

• Original source link unavailable